TP53 and neoplasm: Taken together, our data show that downregulation of PTHLH reduces MYCN expression, tumor growth, invasion, and migration in a MYCN‐amplified and TP53‐mutated neuroblastoma cell lines exhibiting high levels of PTH1R.